Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies

Antimicrobial resistance (AMR) represents a critical and rapidly escalating threat to global health, food security, and economic development. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve mechanisms to resist the effects of antimicrobial agents designed to eliminate them. The increasing misuse and overuse of antibiotics in human medicine, veterinary practice, and agriculture have significantly accelerated the emergence and dissemination of resistant strains. Consequently, infections that were once easily treatable are becoming increasingly difficult to manage, leading to prolonged illness, increased mortality, and escalating healthcare costs. Mechanistically, AMR arises through multiple pathways, including enzymatic drug degradation, modification of drug targets, activation of efflux pumps, and reduced cellular permeability. Horizontal gene transfer further amplifies resistance dissemination among microbial populations. Globally significant resistant pathogens include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Mycobacterium tuberculosis. Management strategies for AMR involve a multifaceted approach encompassing antimicrobial stewardship programs, infection prevention and control measures, surveillance systems, development of novel antimicrobial agents, and alternative therapies such as bacteriophage therapy and immunotherapy. Advances in molecular diagnostics, genomics, and artificial intelligence have enhanced early detection and targeted treatment approaches. Despite these efforts, challenges such as inadequate global surveillance, limited drug development pipelines, economic constraints, and lack of public awareness persist. This review provides a comprehensive overview of AMR, including its epidemiology, mechanisms, clinical impact, and management strategies, highlighting the urgent need for coordinated global interventions.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-16
DOI
https://doi.org/10.5281/zenodo.20227462
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies

Sakshi Tyagi, Sujata
Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Resistance in Bacteria
article

Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies

Sakshi Tyagi, Sujata
article en

Abstract

Antimicrobial resistance (AMR) represents a critical and rapidly escalating threat to global health, food security, and economic development. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve mechanisms to resist the effects of antimicrobial agents designed to eliminate them. The increasing misuse and overuse of antibiotics in human medicine, veterinary practice, and agriculture have significantly accelerated the emergence and dissemination of resistant strains. Consequently, infections that were once easily treatable are becoming increasingly difficult to manage, leading to prolonged illness, increased mortality, and escalating healthcare costs. Mechanistically, AMR arises through multiple pathways, including enzymatic drug degradation, modification of drug targets, activation of efflux pumps, and reduced cellular permeability. Horizontal gene transfer further amplifies resistance dissemination among microbial populations. Globally significant resistant pathogens include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Mycobacterium tuberculosis. Management strategies for AMR involve a multifaceted approach encompassing antimicrobial stewardship programs, infection prevention and control measures, surveillance systems, development of novel antimicrobial agents, and alternative therapies such as bacteriophage therapy and immunotherapy. Advances in molecular diagnostics, genomics, and artificial intelligence have enhanced early detection and targeted treatment approaches. Despite these efforts, challenges such as inadequate global surveillance, limited drug development pipelines, economic constraints, and lack of public awareness persist. This review provides a comprehensive overview of AMR, including its epidemiology, mechanisms, clinical impact, and management strategies, highlighting the urgent need for coordinated global interventions.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 9%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies — Sakshi Tyagi, Sujata · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS